Relay Therapeutics is a precision medicines company in the clinical stage of drug discovery. The company is aimed at enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Its lead product candidates include RLY-4008, RLY-2608, and RLY-1971, which are designed to treat various types of advanced or metastatic solid tumors.